PRICE T ROWE ASSOCIATES INC /MD/ - SALIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$27,006,000
-74.3%
156,273
-82.9%
0.01%
-72.7%
Q4 2014$105,156,000
+187.0%
914,873
+290.2%
0.02%
+175.0%
Q3 2014$36,634,000
+67.9%
234,473
+32.6%
0.01%
+60.0%
Q2 2014$21,817,000
+29.2%
176,873
+8.5%
0.01%
+25.0%
Q1 2014$16,886,000
-41.5%
162,973
-49.2%
0.00%
+33.3%
Q4 2013$28,848,000
-9.4%
320,746
-32.6%
0.00%
-62.5%
Q3 2013$31,826,000
-49.0%
475,873
-49.5%
0.01%0.0%
Q2 2013$62,350,000942,5460.01%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 467,943$30,954,00011.01%
TANG CAPITAL MANAGEMENT LLC 300,000$19,845,0007.82%
OAK RIDGE INVESTMENTS LLC 1,382,895$91,478,0002.87%
SECTOR GAMMA AS 147,001$9,724,0002.84%
Credo Capital Management, LLC 38,869$2,571,0001.98%
Cardinal Capital Management 48,226$3,190,0001.89%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 626,800$41,463,0001.68%
HERNDON CAPITAL MANAGEMENT LLC 1,284,472$84,967,823,0001.27%
CATAPULT CAPITAL MANAGEMENT LLC 45,000$2,977,0001.24%
Pier Capital, LLC 108,556$7,181,0001.10%
View complete list of SALIX PHARMACEUTICALS INC shareholders